The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Genus Set To Post Strong Interim Growth, Beat Prior Annual Guidance

Mon, 18th Jan 2021 08:35

(Alliance News) - Animal genetics company Genus PLC on Monday said it expects to post a notable increase in profit and revenue for the first half of its financial year.

Though growth in the second half is expected to be less strong, it is still set to beat previous annual profit growth expectations.

Shares in Genus were up 4.0% at 4,486.00 pence in London in morning trading.

Genus sells "semen, embryos and breeding animals with superior genetics to those animals currently in farms" under trademarks ABS and PIC. ABS focuses on dairy and beef cattle products and PIC on pigs.

For the six months ended December 31, Genus expects to post an adjusted pretax profit of between GBP47.0 million and GBP49.0 million, up as much as 34% from GBP36.6 million a year before.

Adjusted figures add back net valuation movement on biological assets, amortisation of acquired intangible assets, and other items.

For the six months, revenue is expected to be between GBP285.0 million and GBP287.0 million, an up to 6.0% increase from GBP270.7 million the prior year.

Genus explained that it experienced: "High growth in volumes, revenue and adjusted operating profit were achieved across the groups' operations by both PIC and ABS."

The company said business trends remained consistent with those reported at the time of its annual general meeting in November. This includes additional "strong growth" from PIC in China and ABS in Brazil, India, Russia, and China.

Genus expects to post its interim results on February 25.

In terms of outlook, Genus said: "The prevalence of Covid-19 across the globe has increased substantially since the trading update provided in November and Genus expects there will continue to be some challenges for our customers and employees for the remainder of our financial year, despite the prospect of better conditions as vaccines are being made available.

"However, based on the strong first half trading performance and the current momentum of PIC and ABS, the board currently anticipates that although growth in the second half is likely to be lower than experienced in the first half, Genus will perform ahead of its previous profit growth expectations for the financial year ending 30 June 2021."

By Anna Farley; annafarley@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
30 Apr 2024 09:46

LONDON BROKER RATINGS: Deutsche says buy Barr, Britvic and Fevertree

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

21 Mar 2024 15:00

UK dividends calendar - next 7 days

22 Feb 2024 14:23

UK dividends calendar - next 7 days

22 Feb 2024 11:08

Genus touts programme to boost investment returns as profit declines

(Alliance News) - Genus PLC on Thursday reported a profit fall as its dairy business in China was "particularly" challenged, but said it took decisive...

22 Feb 2024 08:42

Genus holds gloomy guidance as tough conditions persist

(Sharecast News) - There were few surprises in Genus's interim results on Thursday after a detailed trading update from the animal genetics company ju...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.